Guess Who Picked Health Insurance Innovations Inc. (NASDAQ:HIIQ) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Health Insurance Innovations Inc. (NASDAQ:HIIQ) reported that Kosloske Michael W. has picked up 3,841,767 of common stock as of 2017-03-17.
The acquisition brings the aggregate amount owned by Kosloske Michael W. to a total of 3,841,767 representing a 24.38% stake in the company.
For those not familiar with the company, Health Insurance Innovations, Inc. is a developer, distributor and virtual administrator of individual and family health insurance plans and supplemental products. The Company sells individual and family insurance plans (IFP) that include short-term medical (STM) insurance plans and hospital indemnity plans. The Company operates through Insurance Plan Development and Distribution (IPD) segment. Its STM plans cover individuals for over 360 days with a range of co-pay and deductible options. Its individual major medical (IMM) plans cover prescription drugs, pre-existing conditions and preventive care, while STM plans provide optional coverage for prescription drugs. The Company’s hospital indemnity plans provide a daily cash benefit for hospital treatment and doctor office visits, as well as accidental injury and death or dismemberment benefits. It provides supplemental insurance products, including pharmacy benefit cards, dental plans, vision plans and cancer/critical illness plans.
A glance at Health Insurance Innovations Inc. (NASDAQ:HIIQ)’s key stats reveals a current market capitalization of 257.67 Million based on 8.04 Million shares outstanding and a price at last close of $16.58 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-03-09, Murley picked up 9,000 at a purchase price of $16.09. This brings their total holding to 25,700 as of the date of the filing.
On the sell side, the most recent transaction saw Wang unload 3,002 shares at a sale price of $16.95. This brings their total holding to 246,001.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Health Insurance Innovations Inc. (NASDAQ:HIIQ) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Hamilton Lane Inc. (NASDAQ:HLNE) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Hamilton Lane Inc. (NASDAQ:HLNE) reported that Hla Investments Llc. has picked up 36,948,717 of common stock as of 2017-03-17.
The acquisition brings the aggregate amount owned by Hla Investments Llc. to a total of 36,948,717 representing a 65.9% stake in the company.
For those not familiar with the company, Hamilton Lane Incorporated is a global private markets investment solutions provider. The Company works with its clients to conceive, structure, build out, manage and monitor portfolios of private markets funds and direct investments, and it helps them access a set of such investment opportunities around the world. It offers a range of investment solutions across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity and venture capital. These solutions are constructed from a range of investment types, including primary investments in funds managed by third-party managers, direct/co-investments alongside such funds and acquisitions of secondary stakes in such funds, with a range of its clients utilizing multiple investment types. These solutions are offered in a range of formats covering some or all phases of private markets investment programs, such as Customized Separate Accounts and Specialized Funds.
A glance at Hamilton Lane Inc. (NASDAQ:HLNE)’s key stats reveals a current market capitalization of 365.95 Million based on 18.85 Million shares outstanding and a price at last close of $19.26 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-03-06, Delgado-Moreira picked up 2,800 at a purchase price of $16.00. This brings their total holding to 1,553,765 as of the date of the filing.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Hamilton Lane Inc. (NASDAQ:HLNE) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Concert Pharmaceuticals Inc. (NYSE:CNCE) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Concert Pharmaceuticals Inc. (NYSE:CNCE) reported that Great Point Partners has picked up 2,101,301 of common stock as of 2017-03-16.
The acquisition brings the aggregate amount owned by Great Point Partners to a total of 2,101,301 representing a 9.41% stake in the company.
For those not familiar with the company, Concert Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drugs. The Company operates through the development of pharmaceutical products on its own behalf or in collaboration with others segment. It has clinical candidates under development, including AVP-786, CTP-656, CTP-730 and JZP-386. The Company’s deuterated chemical entity platform (DCE Platform) enables it to identify compounds for deuteration and to design, evaluate, develop and manufacture deuterated compounds. The Company is utilizing its DCE Platform to discover and develop product candidates for a range of indications. The Company’s product candidate, CTP-656, is a next generation potentiator that the Company is initially developing for the treatment of cystic fibrosis in patients having gating mutations, including the G551D mutation. AVP-786 is a combination of a deuterated dextromethorphan analog and a low dose of quinidine.
A glance at Concert Pharmaceuticals Inc. (NYSE:CNCE)’s key stats reveals a current market capitalization of 357.71 Million based on 22.33 Million shares outstanding and a price at last close of $16.19 share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-05-10, Tung picked up 19,610 at a purchase price of $10.55. This brings their total holding to 538,965 as of the date of the filing.
On the sell side, the most recent transaction saw Hutt unload 22,123 shares at a sale price of $9.81. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Concert Pharmaceuticals Inc. (NYSE:CNCE) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Comstock Resources Inc. (NYSE:CRK) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Comstock Resources Inc. (NYSE:CRK) reported that Westcott Carl H has picked up 1,135,602 of common stock as of 2017-03-16.
The acquisition brings the aggregate amount owned by Westcott Carl H to a total of 1,135,602 representing a 7.47% stake in the company.
For those not familiar with the company, Comstock Resources, Inc. is an energy company engaged in the acquisition, exploration, development and production of oil and natural gas in the United States. The Company operates in the segment of exploration and production of oil and natural gas. The Company’s oil and gas operations are concentrated in Texas and Louisiana. Its operations are focused in two operating areas: East Texas/North Louisiana and South Texas. The Company’s properties in the East Texas/North Louisiana region include approximately 80,660 acres in the Haynesville or Bossier shale formations. The Company’s Eagleville field includes approximately 30,220 acres located in the oil window of the Eagle Ford shale in South Texas. The Company owns interests in over 1,575 producing oil and natural gas wells, and operates over 950 of these wells. The Company owns interests in over 20 wells in the Rosita field, located in Duval County, Texas.
A glance at Comstock Resources Inc. (NYSE:CRK)’s key stats reveals a current market capitalization of 138.97 Million based on 15.20 Million shares outstanding and a price at last close of $8.90 share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-11-15, Martin picked up 5,500 at a purchase price of $8.95. This brings their total holding to 34,524 as of the date of the filing.
On the sell side, the most recent transaction saw Allison unload 8,000 shares at a sale price of $10.12. This brings their total holding to 393,919.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Comstock Resources Inc. (NYSE:CRK) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.